medline.ch Onkologie Urologische Tumoren

	Functional footprints of homologous recombination deficiency in prostate cancer revealed by ctDNA fragmentation and transcription factor accessibility. Br J Cancer Vlachos G, Moser T, Lazzeri I, Moser MJ, Glawitch L, Bauernhofer ET, Eberhard A, Beichler C, Sadeghi H, Blatterer J, Kühberger S, Monsberger N, Terbuch A, Kashofer K, Geigl JB, Bauernhofer T, Heitzer E. PMID: 41514011 [PubMed - as supplied by publisher]
	A novel prognostic nomogram for elderly renal cell carcinoma patients with lung metastases. Sci Rep Li Z, Liu M, Wang X, Wang F. PMID: 41513983 [PubMed - as supplied by publisher]
	Heterogeneity in Treatment Effects of Reduced Versus Standard Dose of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer. Cancer Med Fukuokaya W, Mori K, Yanagisawa T, Ito K, Urabe F, Rajwa P, Shariat SF, Kimura T, Hirakawa A. PMID: 41513590 [PubMed - indexed for MEDLINE]
	Noninvasive Prediction of Perineural Invasion and Lymphovascular Invasion in Prostate Cancer Using bpMRI Radiomic Signatures. Acad Radiol Zhang YF, Zhou C, Liu D, Chen H, Wang Q, Hu H, He H, Wang J, Zhang W, Wu X, Ren Y, Zhou F. PMID: 41513575 [PubMed - as supplied by publisher]
	Ultra-sensitive optical fiber SPR biosensor for assisted diagnosis of prostate cancer by label-free detection of miRNA-21. Anal Chim Acta Wang J, Deng M, Wang C, Niu K, Wang N, Li J, Xia B, Ding L, Yang H, Chen X, Zhu J. PMID: 41513377 [PubMed - indexed for MEDLINE]
	Lipid Dysregulation in Renal Cancer: Drivers of Tumor Growth and Determinants of Treatment-Induced Toxicity. Semin Cancer Biol Alnukhali M, Fornoni A, Pollack A, Ahmad A. PMID: 41513115 [PubMed - as supplied by publisher]
	MicroRNAs in Prostate Cancer Liquid Biopsies: Early Detection, Prognosis, and Treatment Monitoring. Cells Yaghoubi SM, Zare E, Jafari Dargahlou S, Jafari M, Azimi M, Khoshnazar M, Shirjang S, Mansoori B. PMID: 41511367 [PubMed - indexed for MEDLINE]
	The Role of Selenium as an Antioxidant in the Treatment of Renal Cell Carcinoma. Cureus El Menawy Z, Hmoud H, Taher M, Atef T, Elsharkawi I, Ranade AV. PMID: 41510455 [PubMed]
	Predictive impact of PI-RADS 3 lesion volume/total prostate volume ratio in prostate cancer diagnosis in biopsy-naÃ¯ve patients. Turk J Med Sci Özsoy E, Kutluhan MA, Tokuç E, Kayar R, Demir S, Meriç K, Öztürk M. PMID: 41509953 [PubMed - indexed for MEDLINE]
	Assessing the efficiency of methods to teach adolescents about testicular cancer and testicular self-examination. Turk J Med Sci Gül Güven A, Jafari L, Günel MD, Akbulut Ö. PMID: 41509935 [PubMed - indexed for MEDLINE]
	Testicular cancer in intersex individuals: A systematic review for clinical practice. Int J Cancer Jones NC, Madhavaram A, Haver MK, Quinn GP. PMID: 41508675 [PubMed - as supplied by publisher]
	Pretreatment predictive factors for primary resistance to nivolumab plus ipilimumab in advanced renal cell carcinoma: a multicenter collaborative study. Jpn J Clin Oncol Masui K, Hayata N, Yamasaki T, Yamaguchi T, Kanno T, Ito N, Yoshimura K, Masui S, Segawa T, Kanamaru S, Okumura K, Onishi H, Shichiri Y, Ishitoya S, Sumiyoshi T, Kita Y, Goto T, Kobayashi T, Sawada A. PMID: 41508296 [PubMed - as supplied by publisher]
	Clinical validation of UroCAD test for upper tract urothelial carcinoma detection: results from a prospective multi-center study. J Hematol Oncol Yang G, Zeng S, He W, Zhang L, Xu C, Pan J, Xue W. PMID: 41508041 [PubMed - indexed for MEDLINE]
	Modeling primary immunotherapy resistance in metastatic bladder cancer: a syngeneic, bioluminescent mouse model. Cancer Cell Int Xu D, Jacob JJ, Wieczorek K, Wang L, Yu H, Wang J, Xu B, Hussein AA, Guru K, Goodrich DW, Li Q. PMID: 41507921 [PubMed - as supplied by publisher]
	Immunotherapy combinations in favourable risk score metastatic renal cell carcinoma, an individual patients data metanalysis. BMC Cancer Di Civita MA, Marinelli D, Michetti VM, Artemi A, Ballario A, Torchia A, Pappalardo L, Pecoraro M, Speranza I, Sciarra A, Panebianco V, Roberto M, Santini D. PMID: 41507833 [PubMed - as supplied by publisher]
	Burden of prostate cancer in older adults, 1990-2021: a systematic analysis based on the global burden of disease study 2021. BMC Geriatr Ding W, Li L, Wang ZL, Liu YQ, Wang JW, Tao LS. PMID: 41507812 [PubMed - as supplied by publisher]
	Zonal origin combined with IVIM parameters could predict ISUP risk groups of prostate cancer. Br J Radiol Zhong J, Che Z, Qin X, Zhang Y, Yang Q, Ding J. PMID: 41507079 [PubMed - as supplied by publisher]
	Effects of Causal and Noncausal Components of Screening on Prostate Cancer Mortality: A Mediation Analysis from the Dutch, Finnish, and Swedish Centers of the European Randomized Study of Screening for Prostate Cancer. Eur Urol Oncol Remmers S, Talala K, Roobol MJ, Hugosson J, Arnsrud Godtman R, Nieboer D, Auvinen A, ERSPC Rotterdam, Sweden, and Finland study groups. PMID: 41507018 [PubMed - as supplied by publisher]
	Feasibility of Recruitment, Perceived Genetic Risk and Susceptibility Beliefs, and Saliva Sample Collection in a Community-Based Prostate Cancer Genetic Risk Pilot Study. Am J Mens Health Boxtha C, El-Kolalli S, Denis J, O'Neil A, Vadaparampil ST, Abdulla R, Park H, Park JY, Gwede CK. PMID: 41506624 [PubMed - indexed for MEDLINE]
	Long-term outcomes of prostate cancer patients with metastases in the anterior fat pad and pelvic lymph nodes: Nodal upstaging without worse long-term outcomes. Hum Pathol Yu B, Zhou X, Bian F, Yan F, Franz F. PMID: 41506607 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 175103

Seite 1 von 8756

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung